Effects of probiotics on experimental necrotizing enterocolitis: A systematic review and meta-analysis

Pediatric Research

Volumn 83, Issue 1, 2018, Pages 16-22

  Athalye Jape, Gayatri ^a,b,c   Rao, Shripada ^a,c   Patole, Sanjay ^b,c  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b KEM Hospital for Women   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ANIMAL MODEL; EMBASE; EXPERIMENTAL DISEASE; INTERVENTION STUDY; LEPORIDAE; MEDLINE; META ANALYSIS; MOUSE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PIGLET; PRIORITY JOURNAL; QUAIL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; REVIEW; SYSTEMATIC REVIEW; WEB OF SCIENCE; ANIMAL; CONDITIONED MEDIUM; DISEASE MODEL; DYSBIOSIS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NEWBORN; PIG; PREMATURITY; RISK;

ANIMALS; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; DYSBIOSIS; ENTEROCOLITIS, NECROTIZING; HUMANS; IMMUNE SYSTEM; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; MICE; PROBIOTICS; QUAIL; RABBITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RISK; SWINE;

EID: 85042030536     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2017.218     Document Type: Review

References (96)

1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364: 255-64.
2. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006;368:1271-83.
3. Griffin IJ, Tancredi DJ, Bertino E, et al. Postnatal growth failure in very low birthweight infants born between 2005 and 2012. Arch Dis Child Fetal Neonatal Ed 2016;101:F50-5.
4. Thyoka M, De Coppi P, Eaton S, et al. Advanced necrotizing enterocolitis. Part 1: Mortality. Eur J Pediatr Surg 2012;22:8-12.
5. Kelleher J, Mallick H, Soltau TD, et al. Mortality and intestinal failure in surgical necrotizing enterocolitis. J Pediatr Surg 2013;48:568-72.
6. Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed 2007;92:F193-8.
7. Shah TA, Meinzen-Derr J, Gratton T, et al. Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation. J Perinatol 2012;32: 552-8.
8. Wadhawan R, Oh W, Hintz SR, et al. NICHD Neonatal Research Network. Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis. J Perinatol 2014;34:64-70.
9. Pike K, Brocklehurst P, Jones D, et al. Outcomes at 7 years for babies who developed neonatal necrotising enterocolitis: the ORACLE Children Study. Arch Dis Child Fetal Neonatal Ed 2012;97:F318-22.
10. Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. Arch Pediatr Adolesc Med 2007;161:583-90.
11. Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005;115:696e703.
12. Fitzgibbons SC, Ching Y, Yu D, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009;44: 1072-5.
13. Luig M, Lui KNSW &ACT NICUS Group. Epidemiology of necrotizing enterocolitis-Part I: Changing regional trends in extremely preterm infants over 14 years. J Paediatr Child Health 2005;41:169-73.
14. Salhab WA, Perlman JM, Silver L, et al. Necrotizing enterocolitis and neurodevelopmental outcome in extremely low birth weight infants o1000 g. J Perinatol 2004;24:534-40.
15. Bisquera JA, Cooper TR, Berseth CL. Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 2002;109:423-8.
16. Ganapathy V, Hay JW, Kim JH, et al. Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: a retrospective longitudinal study among infants enrolled in Texas Medicaid. BMC Pediatr 2013;13:127.
17. Torrazza RM, Li N, Neu J. Decoding the enigma of necrotizing enterocolitis in premature infants. Pathophysiology 2014;21:21-7.
18. Choi YY. Necrotizing enterocolitis in newborns: update in pathophysiology and newly emerging therapeutic strategies. Korean J Pediatr 2014;57:505-13.
19. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014;4:CD005496.
20. Lau CS, Chamberlain RS. Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis. J Pediatr Surg 2015;50:1405-2.
21. Sawh SC, Deshpande S, Jansen S, et al. Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ 2016;4:e2429.
22. Wang XL, Li X, Kang L, et al. Prophylactic probiotics for preventing necrotizing enterocolitis and reducing mortality in very low birth weight infants: a meta-analysis. Zhongguo Dang Dai Er Ke Za Zhi 2015;17:852-.
23. Rao RK, Samak G. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Curr Nutr Food Sci 2013;9:99-107.
24. Ewaschuk JB, Diaz H, Meddings L, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 2008;295:G1025-34.
25. Walker A. Intestinal colonization and programming of the intestinal immune response. J Clin Gastroenterol 2014;48:S8-11.
26. Garrido D, Barile D, Mills DA. A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract. Adv Nutr 2012;3: 415S-21S.
27. Di Mauro A, Neu J, Riezzo G, et al. Gastrointestinal function development and microbiota. Ital J Pediatr 2013;39:15.
28. Denayer T, Stöhr T, Van Roy M. Animal models in translational medicine: validation and prediction. New Horiz Transl Med 2014;2:5-11.
29. Ritskes-Hoitinga M, Leenaars M, Avey M, et al. Systematic reviews of preclinical animal studies can make significant contributions to health care and more transparent translational medicine [editorial]. Cochrane Database Syst Rev 2014;3:ED000078.
30. Pound P, Ebrahim S, Sandercock P, et al. Where is the evidence that animal research benefits humans? BMJ 2004;328:514-7.
31. Gopalakrishnan S, Ganeshkumar P. Systematic reviews and metaanalysis: understanding the best evidence in primary healthcare. J Family Med Prim Care 2013;2:9-14.
32. Nordmann AJ, Kasenda B, Briel M. Meta-analyses: what they can and cannot do. Swiss Med Wkly 2012;142:w13518.
33. Hooijmans CR, Ritskes-Hoitinga M. Progress in using systematic reviews of animal studies to improve translational research. PLoS Med 2013;10: e1001482.
34. Sandercock P, Roberts I. Systematic reviews of animal experiments. Lancet 2002;360:586.
35. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9.
36. Lu P, Sodhi CP, Jia H, et al. Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol 2014;306:G917-28.
37. Hooijmans CR, Rovers MM, de Vries RB, et al. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol 2014;14:43.
38. Higgins JPTG, Higgins S Cochrane handbook of systematic reviews of interventions. Version 5.1.0. 2011; The Cochrane Collaboration available at www.handbook.cochrane.org Accessed 16 August 2016.
39. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001;54:1046-55.
40. Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines: 12. Preparing summary of findings tables binary outcomes. J Clin Epidemiol 2013;66:158-72.
41. Wei D, Tang K, Wang Q, et al. The use of GRADE approach in systematic reviews of animal studies. J Evid Based Med 2016;9:98-104.
42. Good M, Sodhi CP, Ozolek JA, et al. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. Am J Physiol Gastrointest Liver Physiol 2014;306:G1021-32.
43. Satoh T, Izumi H, Iwabuchi N, et al. Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model. Benef Microbes 2015;7:1-8.
44. Siggers RH, Siggers J, Boye M, et al. Early administration of probiotics alters bacterial colonization and limits diet-induced gut dysfunction and severity of necrotizing enterocolitis in preterm pigs. J Nutr 2008;138:1437-44.
45. Cilieborg MS, Thymann T, Siggers R, et al. The incidence of necrotizing enterocolitis is increased following probiotic administration to preterm pigs. J Nutr 2011;141:223-30.
46. Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009;297:G940-9.
47. Underwood MA, Arriola J, Gerber CW, et al. Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res 2014;76:326-3.
48. Underwood MA, Kananurak A, Coursodon CF, et al. Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses. Pediatr Res 2012;71:546-1.
49. Wu SF, Chiu HY, Chen AC, et al. Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model. J Pediatr Gastroenterol Nutr 2013;57:23-8.
50. Ling X, Linglong P, Weixia D, et al. Protective effects of bifidobacterium on intestinal barrier function in LPS-induced enterocyte barrier injury of Caco-2 monolayers and in a rat NEC model. PLoS ONE 2016;11: e0161635.
51. Shiou SR, Yu Y, Guo Y, et al. Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury. PLoS ONE 2013;8:e65108.
52. McVay MR, Boneti C, Habib CM, et al. Formula fortified with live probiotic culture reduces pulmonary and gastrointestinal bacterial colonization and translocation in a newborn animal model. J Pediatric Surg 2008;43:25-9.
53. Bergmann KR, Liu SX, Tian R, et al. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol 2013;182:1595-606.
54. Zhou W, Lv H, Li MX, et al. Protective effects of bifidobacteria on intestines in newborn rats with necrotizing enterocolitis and its regulation on TLR2 and TLR4. Genet Mol Res 2015;14:11505-4.
55. Liu Y, Fatheree NY, Mangalat N, et al. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kappaB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 2012;302:G608-17.
56. Goncalves FL, Soares LM, Figueira RL, et al. Evaluation of the expression of I-FABP and L-FABP in a necrotizing enterocolitis model after the use of Lactobacillus acidophilus. J Pediatr Surg 2015;50:543-9.
57. Caplan MS, Miller-Catchpole R, Kaup S, et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 1999;117:577-83.
58. Olson JK, Rager TM, Navarro JB, et al. Harvesting the benefits of biofilms: a novel probiotic delivery system for the prevention of necrotizing enterocolitis. J Pediatr Surg 2016;51:936-41.
59. Castro E, Cofré J, Mellado JP, et al. Induction of necrotizing enterocolitis in non-premature Sprague-Dawley rats and the effect of administering breast milk-isolated Lactobacillus salivarius LPLM-O1. Food Nutr Sci 2014;5:1255-60.
60. D'Souza A, Cai CL, Kumar D, et al. Cytokines and Toll-like receptor signaling pathways in the terminal ileum of hypoxic/hyperoxic neonatal rats: benefits of probiotics supplementation. Am J Transl Res 2012;4: 187-97.
61. D'Souza A, Fordjour L, Ahmad A, et al. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res 2010;67:526-31.
62. Weng M, Ganguli K, Zhu W, et al. Conditioned medium from Bifidobacteria infantis protects against Cronobacter sakazakii-induced intestinal inflammation in newborn mice. Am J Physiol Gastrointest Liver Physiol 2014;306:G779-87.
63. Hunter CJ, Williams M, Petrosyan M, et al. Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakiiinduced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 2009;77:1031-43.
64. Akisu M, Baka M, Yalaz M, et al. Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Eur J Pediatr Surg 2003;13:319-23.
65. Butel MJ, Roland N, Hibert A, et al. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. J Med Microbiol 1998;47:391-9.
66. Liu Y, Tran DQ, Fatheree NY, et al. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2014;307:G177-86.
67. Mirpuri J, Sotnikov I, Myers L, et al. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. PLoS ONE 2012;7: e51955.
68. Catala I, Butel MJ, Bensaada M, et al. Oligofructose contributes to the protective role of bifidobacteria in experimental necrotising enterocolitis in quails. J Med Microbiol 1999;48:89-94.
69. Lin PW, Myers LE, Ray L, et al. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 2009;47:1205-1.
70. Khailova L, Mount Patrick SK, Arganbright KM, et al. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010;299: G1118-27.
71. Ganguli K, Walker WA. Probiotics in the prevention of necrotizing enterocolitis. J Clin Gastroenterol 2011;45 (Suppl): S133-8.
72. Vandenplas Y, Veereman-Wauters G. Probiotics: fishing in the ocean. J Pediatr Gastroenterol Nutr 2012;54:4-5.
73. Sanders ME Is it time to consider generic probiotic effects? California Dairy Research Foundation 1/3/2011. http://cdrf.org/2013/03/01/is-ittime-to-consider-generic-probiotic-effects/. Accessed 9 October 2016.
74. Deshpande G, Rao S, Patole S, et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921-30.
75. Olsen R, Greisen G, Schrøder M, et al. Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies. Neonatology 2016;109:105-2.
76. Dermyshi E, Wang Y, Yan C, et al. The "Golden Age" of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology 2017;112:9-23.
77. Neu J. Routine probiotics for premature infants: let's be careful!. J Pediatr 2011;158:672-4.
78. Modi N. Probiotics and necrotising enterocolitis: the devil (as always) is in the detail. Neonatology 2014;105:71-3.
79. Neu J. Probiotics and necrotizing enterocolitis. Clin Perinatol 2014;41: 967-78.
80. Jacobs SE, Tobin JM, Opie GF, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013;132:1055-62.
81. Costeloe K, Hardy P, Juszczak E, et al. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016;387:649-0.
82. Sangild PT, Ney DM, Sigalet DL, et al. Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges. Am J Physiol Gastrointest Liver Physiol 2014;307:G1147-68.
83. Moran CJ, Ramesh A, Brama PA, et al. The benefits and limitations of animal models for translational research in cartilage repair. J Exp Orthop 2016;3:1.
84. Martinez MInterspecies differences in physiology and pharmacology: extrapolating preclinical data to human populationsIn:Rogge MC, Taft DReds. Preclinical Drug Development 2. Boca Raton, FL, USA: Taylor and Francis Group, 2009: 35-70.
85. Rao SC, Athalye-Jape GK, Deshpande GC, et al. Probiotic supplementation and late-onset sepsis in preterm infants: a meta-analysis. Pediatrics 2016;137:e20153684.
86. Zbinden A, Zbinden R, Berger C, et al. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107:56-9.
87. Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60:924-7.
88. Centers for Disease Control and Prevention Fatal gastrointestinal mucormycosis in an infant following use of contaminated ABC dophilus powder from Solgar Inc, 2014. Accessed 3 August 2017. Available from http://www.cdc.gov.pklibresources.health.wa.gov.au/ fungal/rhizopus-investigation.html.
89. Barrington KJ, Ryan CA, Finer NN. Effects of magnesium sulfate in a newborn piglet meconium aspiration model. J Perinatol 2000;20: 373-8.
90. Travadi J, Patole S, Charles A, et al. Pentoxifylline reduces the incidence and severity of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 2006;60:185-9.
91. Erdener D, Bakirtas F, Alkanat M, et al. Pentoxifylline does not prevent hypoxia/reoxygenation-induced necrotizing enterocolitis. An experimental study. Biol Neonate 2004;86:29-33.
92. Neu J. Necrotizing enterocolitis: the mystery goes on. Neonatology 2014;106:289-95.
93. Baker D, Lidster K, Sottomayor A, et al. Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for preclinical animal studies. PLoS Biol 2014;12:e1001756.
94. Avey MT, Fenwick N, Griffin G. The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs. J Am Assoc Lab Anim Sci 2015;54:153-62.
95. Burdge GC. Improving standards for reporting studies involving humans and experimental animals in the British Journal of Nutrition and in the Journal of Nutritional Science. Br J Nutr 2014;112:1423-4.
96. Hooijmans CR, de Vries R, Leenaars M, et al. Improving planning, design, reporting and scientific quality of animal experiments by using the Gold Standard Publication Checklist, in addition to the ARRIVE guidelines. Br J Pharmacol 2011;162:1259-60.